Mucavex (Bromhexine Hydrochloride)

Bromhexine Hydrochloride, the active ingredient in Mucavex, is a mucolytic agent presented as an oral formulation for systemic use. It helps to thin and loosen mucus in the respiratory tract, facilitating expectoration in patients with productive coughs associated with bronchitis and other infections.

GNH USA supplies Mucavex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory support for global distribution.

Mucavex (bromhexine hydrochloride) is used as a mucolytic in respiratory conditions characterized by thick, sticky sputum. - Acute bronchitis: reduces mucus viscosity to improve cough clearance. - Chronic bronchitis: facilitates expectoration and eases chronic productive cough. - Respiratory tract infections with productive cough: aids mucus clearance and symptom relief.

Bromhexine may cause a range of adverse reactions, which are grouped by frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Vomiting: occasional emesis after dosing. - Abdominal discomfort: cramping or pain. - Diarrhoea: loose stools. - Taste disturbance: altered or metallic taste. - Skin rash: mild erythema or pruritus.

Serious or Rare Side Effects: - Allergic reactions: anaphylaxis, urticaria, angioedema. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic enzyme elevation: possible liver function changes. - Neutropenia: reduced white blood cell count. - Eosinophilia: increased eosinophil levels. - Bronchospasm: sudden tightening of airway muscles.

When prescribing Mucavex, consider the following precautions to ensure safe use. - Assess renal function: adjust use in severe impairment. - Monitor gastrointestinal tolerance: advise patients to take with food if upset occurs. - Avoid in known hypersensitivity: discontinue if allergic signs appear. - Caution in asthma: may provoke bronchospasm in susceptible individuals. - Pregnancy and lactation: use only if clinical benefit outweighs potential risk. - Store at room temperature: keep in the original pack, protect from moisture and light.

Bromhexine can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Anticholinergic agents: may diminish mucolytic effect. - Cytotoxic chemotherapy: increased risk of pulmonary toxicity.

Moderate Interactions (Monitor Closely): - Macrolide antibiotics (e.g., erythromycin): may raise bromhexine plasma levels. - Bronchodilators: additive risk of bronchospasm. - Warfarin: possible alteration of INR, requiring closer monitoring.